English

BIO-SOLUTIONS CORP.

EDGAR

GLUC Registration statement (S-1) · filed 2022-06-01

51 filing records in this dataset, filed from 2008-04-10 to 2022-06-01. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

214 thousand USD

2022 Q1 · USD

Exact inputs and evidence

Revenue: 213813 USD Source

Operating margin

-89.35%

2022 Q1 · %

Exact inputs and evidence

Operating Income: -191049 USD Source
Revenue: 213813 USD Source

Operating cash flow

-86.2 thousand USD

2022 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -86216 USD Source

Cash and cash equivalents: 641 thousand USD 2022-03-31 Source
Exact value

641061 USD
Long-term debt including current maturities: Not available
Shares outstanding: 13.8 million shares 2022-03-31 Source
Exact value

13848630 shares

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2022-06-01.

Financial data available through: 2021-12-31.

Coverage by financial measure

Revenue: 2 of 11 periods available· newest 2021-12-31
Operating income: 8 of 11 periods available· newest 2021-12-31
Net income: 8 of 11 periods available· newest 2021-12-31
Operating cash flow: 8 of 11 periods available· newest 2021-12-31
capital expenditure: No compatible figures in this window
Total assets: 2 of 11 periods available· newest 2021-12-31
Total liabilities: 2 of 11 periods available· newest 2021-12-31
Current assets: 2 of 11 periods available· newest 2021-12-31
Current liabilities: 2 of 11 periods available· newest 2021-12-31
Cash and cash equivalents: 2 of 11 periods available· newest 2021-12-31
long term debt: No compatible figures in this window
Shares outstanding: 2 of 11 periods available· newest 2021-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+98.4%

Prior period

USD 480,713

2020-01-01 – 2020-12-31
Current period

USD 953,681

2021-01-01 – 2021-12-31

Exact inputs and evidence

953681 − 480713 = 472968 USD

480713 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
953681 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · BIO-SOLUTIONS CORP. · 2021-12-31 BIO-SOLUTIONS CORP. (edgar:1420108) Year-over-year change in Revenue: 472968 USD Concept: fundies:Revenue Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420108?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 953681 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420108/000147793222004038/gluc_s1.htm#1350402 Filing: 000147793222004038 Input fundies:Revenue: 480713 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420108/000147793222004038/gluc_s1.htm#1350968 Filing: 000147793222004038
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 138,774

Prior period

−USD 477,678

2020-01-01 – 2020-12-31
Current period

−USD 338,904

2021-01-01 – 2021-12-31

Exact inputs and evidence

-338904 − -477678 = 138774 USD

-477678 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
-338904 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · BIO-SOLUTIONS CORP. · 2021-12-31 BIO-SOLUTIONS CORP. (edgar:1420108) Year-over-year change in Net income: 138774 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420108?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -338904 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420108/000147793222004038/gluc_s1.htm#1613555 Filing: 000147793222004038 Input fundies:NetIncome: -477678 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420108/000147793222004038/gluc_s1.htm#1555316 Filing: 000147793222004038
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 3,802

Prior period

−USD 68,937

2020-01-01 – 2020-12-31
Current period

−USD 72,739

2021-01-01 – 2021-12-31

Exact inputs and evidence

-72739 − -68937 = -3802 USD

-68937 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
-72739 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · BIO-SOLUTIONS CORP. · 2021-12-31 BIO-SOLUTIONS CORP. (edgar:1420108) Year-over-year change in Operating cash flow: -3802 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420108?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -72739 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420108/000147793222004038/gluc_s1.htm#1613790 Filing: 000147793222004038 Input fundies:OperatingCashFlow: -68937 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420108/000147793222004038/gluc_s1.htm#1573955 Filing: 000147793222004038
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2021 2021-01-01 – 2021-12-31

Revenue USD 953,681 100% of revenue
Cost of revenue USD 543,639 57% of revenue
Operating expenses USD 746,161 78% of revenue
Operating income −USD 336,119 −35% of revenue
Tax, interest and other Derived USD 2,785 0.3% of revenue
Net income −USD 338,904 −36% of revenue

Cash

Operating cash flow −USD 72,739 −7.6% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2020 Operating loss: operating costs were 230% of revenue.
2021 Operating loss: operating costs were 135% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2020 2020-01-01 – 2020-12-31	480713	1105068 Derived	-624355	-146677 Derived	-477678	Unavailable	Source 2020-01-01 – 2020-12-31: 480713 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -624355 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -477678 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -68937 USD Inspect Operating Cash Flow Open source
2021 2021-01-01 – 2021-12-31	953681	1289800 Derived	-336119	2785 Derived	-338904	Unavailable	Source 2021-01-01 – 2021-12-31: 953681 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -336119 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -338904 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -72739 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 953.7K 2021

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Revenue	480713	Revenue: 480713 Open source
20212021-12-31	Revenue	953681	Revenue: 953681 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

98.4% 2021

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Year over year	No prior comparable period	Revenue: 480713 Open source
20212021-12-31	Year over year	98.4%	Revenue: 953681 Open source Revenue: 480713 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -35.2% 2021

Net margin -35.5% 2021

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Operating margin	-129.9%	Operating Income: -624355 Open source Revenue: 480713 Open source
20212021-12-31	Operating margin	-35.2%	Operating Income: -336119 Open source Revenue: 953681 Open source
20202020-12-31	Net margin	-99.4%	Net Income: -477678 Open source Revenue: 480713 Open source
20212021-12-31	Net margin	-35.5%	Net Income: -338904 Open source Revenue: 953681 Open source
20202020-12-31	Free cash flow margin	Not reported	Revenue: 480713 Open source Operating Cash Flow: -68937 Open source
20212021-12-31	Free cash flow margin	Not reported	Revenue: 953681 Open source Operating Cash Flow: -72739 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -72.7K 2021

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Operating cash flow	-68937	Operating Cash Flow: -68937 Open source
20212021-12-31	Operating cash flow	-72739	Operating Cash Flow: -72739 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Free cash flow	Unavailable	Operating Cash Flow: -68937 Open source
20212021-12-31	Free cash flow	Unavailable	Operating Cash Flow: -72739 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

0.8% 2021

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Liabilities / assets	40.6%	Total Liabilities: 139761 Open source Total Assets: 344616 Open source
20212021-12-31	Liabilities / assets	0.8%	Total Liabilities: 9555 Open source Total Assets: 1156107 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

120.65× 2021

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Current assets / current liabilities	2.44×	Current Assets: 341321 Open source Current Liabilities: 139761 Open source
20212021-12-31	Current assets / current liabilities	120.65×	Current Assets: 1152812 Open source Current Liabilities: 9555 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2011 2011-01-01 – 2011-12-31	−USD 899,186 Exact value Exact value: -899186 USD 2011-01-01 – 2011-12-31: -899186 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO-SOLUTIONS CORP. · 2011-12-31 BIO-SOLUTIONS CORP. (edgar:1420108) Net Income: -899186 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420108/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -899186 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420108/000147793214002329/bisu-20121231.xml#186523 Filing: 000147793214002329 The citation records this snapshot. The page link may show a newer release later.	−USD 23,302 Exact value Exact value: -23302 USD 2011-01-01 – 2011-12-31: -23302 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIO-SOLUTIONS CORP. · 2011-12-31 BIO-SOLUTIONS CORP. (edgar:1420108) Operating Cash Flow: -23302 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420108/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23302 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420108/000147793214002329/bisu-20121231.xml#189903 Filing: 000147793214002329 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2012 2012-01-01 – 2012-12-31	−USD 399,078 Exact value Exact value: -399078 USD 2012-01-01 – 2012-12-31: -399078 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO-SOLUTIONS CORP. · 2012-12-31 BIO-SOLUTIONS CORP. (edgar:1420108) Net Income: -399078 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420108/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -399078 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420108/000147793214003318/bisu-20131231.xml#121488 Filing: 000147793214003318 The citation records this snapshot. The page link may show a newer release later.	−USD 83,691 Exact value Exact value: -83691 USD 2012-01-01 – 2012-12-31: -83691 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIO-SOLUTIONS CORP. · 2012-12-31 BIO-SOLUTIONS CORP. (edgar:1420108) Operating Cash Flow: -83691 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420108/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -83691 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420108/000147793214003318/bisu-20131231.xml#126341 Filing: 000147793214003318 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2013 2013-01-01 – 2013-12-31	−USD 1.46 million Exact value Exact value: -1459146 USD 2013-01-01 – 2013-12-31: -1459146 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO-SOLUTIONS CORP. · 2013-12-31 BIO-SOLUTIONS CORP. (edgar:1420108) Net Income: -1459146 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420108/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1459146 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420108/000147793215001981/bisu-20141231.xml#51622 Filing: 000147793215001981 The citation records this snapshot. The page link may show a newer release later.	−USD 131,985 Exact value Exact value: -131985 USD 2013-01-01 – 2013-12-31: -131985 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIO-SOLUTIONS CORP. · 2013-12-31 BIO-SOLUTIONS CORP. (edgar:1420108) Operating Cash Flow: -131985 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420108/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -131985 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420108/000147793215001981/bisu-20141231.xml#77063 Filing: 000147793215001981 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2014 2014-01-01 – 2014-12-31	−USD 669,409 Exact value Exact value: -669409 USD 2014-01-01 – 2014-12-31: -669409 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO-SOLUTIONS CORP. · 2014-12-31 BIO-SOLUTIONS CORP. (edgar:1420108) Net Income: -669409 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420108/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -669409 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420108/000147793216009786/gluc-20151231.xml#90387 Filing: 000147793216009786 The citation records this snapshot. The page link may show a newer release later.	−USD 135,352 Exact value Exact value: -135352 USD 2014-01-01 – 2014-12-31: -135352 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIO-SOLUTIONS CORP. · 2014-12-31 BIO-SOLUTIONS CORP. (edgar:1420108) Operating Cash Flow: -135352 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420108/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -135352 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420108/000147793216009786/gluc-20151231.xml#24777 Filing: 000147793216009786 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2015 2015-01-01 – 2015-12-31	−USD 266,064 Exact value Exact value: -266064 USD 2015-01-01 – 2015-12-31: -266064 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO-SOLUTIONS CORP. · 2015-12-31 BIO-SOLUTIONS CORP. (edgar:1420108) Net Income: -266064 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420108/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -266064 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420108/000147793217001354/gluc-20161231.xml#63986 Filing: 000147793217001354 The citation records this snapshot. The page link may show a newer release later.	−USD 115,776 Exact value Exact value: -115776 USD 2015-01-01 – 2015-12-31: -115776 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIO-SOLUTIONS CORP. · 2015-12-31 BIO-SOLUTIONS CORP. (edgar:1420108) Operating Cash Flow: -115776 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420108/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -115776 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420108/000147793217001354/gluc-20161231.xml#205865 Filing: 000147793217001354 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2016-01-01 – 2016-12-31	−USD 410,443 Exact value Exact value: -410443 USD 2016-01-01 – 2016-12-31: -410443 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO-SOLUTIONS CORP. · 2016-12-31 BIO-SOLUTIONS CORP. (edgar:1420108) Net Income: -410443 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420108/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -410443 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420108/000147793217001354/gluc-20161231.xml#63860 Filing: 000147793217001354 The citation records this snapshot. The page link may show a newer release later.	−USD 39,263 Exact value Exact value: -39263 USD 2016-01-01 – 2016-12-31: -39263 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIO-SOLUTIONS CORP. · 2016-12-31 BIO-SOLUTIONS CORP. (edgar:1420108) Operating Cash Flow: -39263 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420108/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -39263 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420108/000147793217001354/gluc-20161231.xml#205682 Filing: 000147793217001354 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2020-01-01 – 2020-12-31	−USD 477,678 Exact value Exact value: -477678 USD 2020-01-01 – 2020-12-31: -477678 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO-SOLUTIONS CORP. · 2020-12-31 BIO-SOLUTIONS CORP. (edgar:1420108) Net Income: -477678 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420108/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -477678 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420108/000147793222004038/gluc_s1.htm#1555316 Filing: 000147793222004038 The citation records this snapshot. The page link may show a newer release later.	−USD 68,937 Exact value Exact value: -68937 USD 2020-01-01 – 2020-12-31: -68937 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIO-SOLUTIONS CORP. · 2020-12-31 BIO-SOLUTIONS CORP. (edgar:1420108) Operating Cash Flow: -68937 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420108/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -68937 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420108/000147793222004038/gluc_s1.htm#1573955 Filing: 000147793222004038 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2021-01-01 – 2021-12-31	−USD 338,904 Exact value Exact value: -338904 USD 2021-01-01 – 2021-12-31: -338904 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO-SOLUTIONS CORP. · 2021-12-31 BIO-SOLUTIONS CORP. (edgar:1420108) Net Income: -338904 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420108/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -338904 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420108/000147793222004038/gluc_s1.htm#1613555 Filing: 000147793222004038 The citation records this snapshot. The page link may show a newer release later.	−USD 72,739 Exact value Exact value: -72739 USD 2021-01-01 – 2021-12-31: -72739 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIO-SOLUTIONS CORP. · 2021-12-31 BIO-SOLUTIONS CORP. (edgar:1420108) Operating Cash Flow: -72739 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1420108/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -72739 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1420108/000147793222004038/gluc_s1.htm#1613790 Filing: 000147793222004038 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

51 filings · 1,439 latest values · 1,439 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001420108, 1420108, GLUC, edgar:1420108

Also known as BIO-SOLUTIONS CORP., Bio-Solutions Corp., GLUCOSE HEALTH, INC., Glucose Health, Inc.

BIO-SOLUTIONS CORP.

Latest quarter

Revenue

Operating margin

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2021 2021-01-01 – 2021-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation